Références
Manner H, Kouti I, May A, et al. Efficacy and safety of hybrid-APC for the ablation of Barrett’s esophagus: results of the pilot series. United European Gastroenterol J 2014;2(S1):A60
Kastelein F, van Olphen S, Spaander M, et al. Impact of surveillance for Barrett’s esophagus on survival of patients with neoplastic progression: result of a large multicenter prospective cohort study. United European Gastroenterol J 2014;2(S1):A73
Duits LC, Phoa KN, Pham TV, et al. The SURF trial preassessment cohort: spatial extent of low grade dysplasia and extent of agreement between expert pathologists are associated with risk of malignant progression. United European Gastroenterol J 2014;2(S1):A74
Krajciova J, Stefanova M, Maluskova J, et al. Is a complete remission of intestinal metaplasia a suitable endpoint in patients undergoing radiofrequency ablation (RFA)? Long term results of RFA treatment in 67 consecutive patients. United European Gastroenterol J 2014;2(S1):A60
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Robaszkiewicz, M. UEGW 2014, Vienne, 20–22 octobre 2014 œsophage de Barrett. Acta Endosc 45, 73–74 (2015). https://doi.org/10.1007/s10190-015-0430-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10190-015-0430-4